Evidence map›Paper›PMID 29972322›Full record

ArticleAmerican journal of physiology. Renal physiology2018

Void spot assay procedural optimization and software for rapid and objective quantification of rodent voiding function, including overlapping urine spots.

Kyle A Wegner, Lisa L Abler, Steven R Oakes, Guneet S Mehta, K Elaine Ritter, Warren G Hill, Bernadette M Zwaans, Laura E Lamb, Zunyi Wang, Dale E Bjorling and 6 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. PIEZO1-mediated mechanosensation links aging to bladder dysfunction.bioRxiv : the preprint server for biology · 2026
    Article
  4. Spoti-find: a novel, open-source void spot assay image analysis tool.American journal of physiology. Renal physiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Mechanisms of prostatic inflammation-mediated male lower urinary tract symptoms.American journal of clinical and experimental urology · 2025
    Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Kyle A WegnerGeorge M. O'Brien Center for Benign Urologic Research, University of Wisconsin-Madison, Wisconsin, and University of Massachusetts Boston, Massachusetts.
Lisa L AblerGeorge M. O'Brien Center for Benign Urologic Research, University of Wisconsin-Madison, Wisconsin, and University of Massachusetts Boston, Massachusetts.
Steven R OakesGeorge M. O'Brien Center for Benign Urologic Research, University of Wisconsin-Madison, Wisconsin, and University of Massachusetts Boston, Massachusetts.
Guneet S MehtaLaboratory for Optical and Computational Instrumentation, University of Wisconsin-Madison , Madison, Wisconsin.
K Elaine RitterDivision of Genetic Medicine, Department of Medicine, Vanderbilt University School of Medicine, Vanderbilt University , Nashville, Tennessee.
Warren G HillDepartment of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School , Boston, Massachusetts.
Bernadette M ZwaansDepartment of Urology, Beaumont Health System, Royal Oak, Michigan.
Laura E LambDepartment of Urology, Beaumont Health System, Royal Oak, Michigan.
Zunyi WangOakland University William Beaumont School of Medicine, Auburn Hills, Michigan.
Dale E BjorlingGeorge M. O'Brien Center for Benign Urologic Research, University of Wisconsin-Madison, Wisconsin, and University of Massachusetts Boston, Massachusetts.
William A RickeGeorge M. O'Brien Center for Benign Urologic Research, University of Wisconsin-Madison, Wisconsin, and University of Massachusetts Boston, Massachusetts.
Jill MacoskaGeorge M. O'Brien Center for Benign Urologic Research, University of Wisconsin-Madison, Wisconsin, and University of Massachusetts Boston, Massachusetts.ORCID 0000-0001-8471-2221
Paul C MarkerGeorge M. O'Brien Center for Benign Urologic Research, University of Wisconsin-Madison, Wisconsin, and University of Massachusetts Boston, Massachusetts.
E Michelle Southard-SmithDivision of Genetic Medicine, Department of Medicine, Vanderbilt University School of Medicine, Vanderbilt University , Nashville, Tennessee.
Kevin W EliceiriGeorge M. O'Brien Center for Benign Urologic Research, University of Wisconsin-Madison, Wisconsin, and University of Massachusetts Boston, Massachusetts.
Chad M VezinaGeorge M. O'Brien Center for Benign Urologic Research, University of Wisconsin-Madison, Wisconsin, and University of Massachusetts Boston, Massachusetts.
University of Wisconsin–Madison · USOakland University · USVanderbilt University · USBeth Israel Deaconess Medical Center · US

Funding

Role of Beta-Catenin in Urinary DysfunctionU54DK104310 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI MACOSKA, JILL A., MARKER, PAUL C · 2014 to 2023
$12.8M
Molecular & Environmental Toxicology Pre-& Postdoctoral Training ProgramT32ES007015 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI CHRISTOPHER A BRADFIELD · 1985 to 2026
$11.5M
Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI NEUL, JEFFREY L · 2015 to 2019
$7.1M
REPRODUCTIVE AND DEVELOPMENTAL TOXICITY OF DIOXINR01ES001332 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI PETERSON, RICHARD EUGENE, VEZINA, CHAD M. · 1985 to 2021
$5.3M
Neural Crest Contributions to the Lower Urinary TractR01DK078158 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SOUTHARD-SMITH, E MICHELLE · 2007 to 2017
$2.1M
Atlas of autonomic and neuromodulatory lineages in the developing lower urinary tractU01DK110804 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SOUTHARD-SMITH, E MICHELLE · 2016 to 2020
$1.9M
Role of DNA methylation in prostate glandular development and urinary functionR01DK099328 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI VEZINA, CHAD M. · 2014 to 2018
$1.6M
Cancer Survivorship Research and Training in Radiation CystitisK01DK114334 · NIDDK · WILLIAM BEAUMONT HOSPITAL RESEARCH INST · PI ZWAANS, BERNADETTE MARGARETHA MARIA · 2018 to 2020
$444k
TCDD Reprograms Prostate Stroma and Causes Fibrosis to Induce Urinary DysfunctionF31ES028594 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI WEGNER, KYLE ALLEN · 2018 to 2019
$54k
NICHD NIH HHS U54 HD083211NIDDK NIH HHS K01 DK114334NIDDK NIH HHS R01 DK078158NIDDK NIH HHS R01 DK099328NIDDK NIH HHS U01 DK110804NIDDK NIH HHS U54 DK104310NIEHS NIH HHS F31 ES028594NIEHS NIH HHS R01 ES001332NIEHS NIH HHS T32 ES007015
6 · The paper itself

Abstract

Mouse urinary behavior is quantifiable and is used to pinpoint mechanisms of voiding dysfunction and evaluate potential human therapies. Approaches to evaluate mouse urinary function vary widely among laboratories, however, complicating cross-study comparisons. Here, we describe development and multi-institutional validation of a new tool for objective, consistent, and rapid analysis of mouse void spot assay (VSA) data. Void Whizzard is a freely available software plugin for FIJI (a distribution of ImageJ) that facilitates VSA image batch processing and data extraction. We describe its features, demonstrate them by evaluating how specific VSA method parameters influence voiding behavior, and establish Void Whizzard as an expedited method for VSA analysis. This study includes control and obese diabetic mice as models of urinary dysfunction to increase rigor and ensure relevance across distinct voiding patterns. In particular, we show that Void Whizzard is an effective tool for quantifying nonconcentric overlapping void spots, which commonly confound analyses. We also show that mouse genetics are consistently more influential than assay design parameters when it comes to VSA outcomes. None of the following procedural modifications to reduce overlapping spots masked these genetic-related differences: reduction of VSA testing duration, water access during the assay period, placement of a wire mesh cage bottom on top of or elevated over the filter paper, treatment of mesh with a hydrophobic spray, and size of wire mesh opening. The Void Whizzard software and rigorous validation of VSA methodological parameters described here advance the goal of standardizing mouse urinary phenotyping for comprehensive urinary phenome analyses.

Indexed as

SoftwareAnimalsDiabetes Mellitus, ExperimentalGoalsMaleMice, TransgenicUrinary BladderUrinationUrodynamicsdiabetic micefree open-source softwareurinary dysfunctionvoiding behaviorvoid spot assay

Identifiers

PMID29972322
PMCPMC6230749
OpenAlexW2810988956

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.